Novel Insights on Use of Doxorubicin to Treat Chemoresistant TNBC by Immunotherapy

Authors

Tze-Chen Hsieh, New York Medical CollegeFollow
Joseph M. Wu, New York Medical College

Journal Title

International Journal of Immunotherapy and Cancer Research

First Page

16

Last Page

18

Document Type

Article

Publication Date

7-2020

Department

Biochemistry and Molecular Biology

Recommended Citation

Hsieh, T., & Wu, J. M. (2020). Novel Insights on Use of Doxorubicin to Treat Chemoresistant TNBC by Immunotherapy. International Journal of Immunotherapy and Cancer Research, 6 (1), 16-18. https://doi.org/10.17352/2455-8591.000024